A new DTPw-HBV/Hib vaccine: Immune memory after primary vaccination and booster dosing in the second year of life

Human Vaccines

Volumn 4, Issue 1, 2008, Pages 60-66

  Gatchalian, Salvacion ^a,b,f   Reyes, Marietta ^c   Bermal, Nancy ^d   Chandrasekaran, Vijayalakshmi ^e   Han, Htay Htay ^f   Bock, Hans L ^f   Lefevre, Inge ^e,g  

^a RESEARCH INSTITUTE FOR TROPICAL MEDICINE   (Philippines)

^b UNIVERSITY OF THE PHILIPPINES   (Philippines)

^c Quirino Memorial Medical Centre   (Philippines)

^d San Juan de Dios Hospital   (Philippines)

^e GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^f GLAXOSMITHKLINE   (Singapore)

^g GbxoSmimKline Biologicals   (Belgium)

Author keywords

Booster; Combined vaccines; Haemophilus influenzae type b; Hepatitis B; Immune memory; Vaccination; Whole cell pertussis

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS TETANUS HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; POLYRIBOSYLRIBITOL PHOSPHATE; RIBITOL;

ANTIBODY RESPONSE; ARTICLE; ASTHMATIC STATE; CLINICAL ARTICLE; DIPHTHERIA; DRUG TOLERABILITY; ERYTHEMA; FEMALE; FEVER; HAEMOPHILUS INFLUENZAE TYPE B; HEPATITIS B; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; INFECTION PREVENTION; INFLUENZA; INJECTION SITE INDURATION; INJECTION SITE SWELLING; JOINT SWELLING; MALE; PAIN; PERTUSSIS; PRESCHOOL CHILD; SEROCONVERSION; SWELLING; TETANUS;

EID: 42449105142     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.4.1.5069     Document Type: Article

References (13)

1. Arístegui J, Usonis V, Coovadia H, Riedemann S, Win KM, Gatchalian S, Bock HL. Facilitating the WHO expanded program of immunization: The clinical profile of a combined diphtheria, pertussis, hepatitis B and Haemophilus influenzae type b vaccine. Int J Infect Dis 2003; 7:143-51.
2. Gatchalian S, Reyes M, Bernal N, Lefevre I, David MP, Han HH, Bock HL, Wolter J, Schuerman L. A new DTPw-HBV/Hib vaccine is immunogenic and safe when administered according to the EPI (Expanded Programme for Immunization) schedule and following hepatitis B vaccination at birth. Human Vaccines 2005; 1:198-203.
3. Woo EJ, Burwen DR, Gatumu SN, Ball R. Vaccine adverse event reporting system working group: Extensive limb swelling after immunization: Reports to the vaccine adverse event reporting system. Clin Infect Dis 2003; 37:351-8.
4. Lagos R, Valenzuela MT, Levine OS, Losonsky GA, Erazo A, Wasserman SS, Levine MM. Economisation of vaccination against Haemophilus influenzae type b: A randomised trial of immunogenicity of fractional-dose and two-dose regimens. Lancet 1998; 351:1472-6.
5. Fernandez J, Balter S, Feris J, Gomez E, Garib Z, Castellanos PL, Sanchez J, Romero-Steiner S, Levine OS. Randomized trial of the immunogenicity of fractional dose regimens of PRP-T Haemophilus influenzae type b conjugate vaccine. Am J Trop Med Hyg 2000; 62:485-90.
6. Romero-Steiner S, Fernandez J, Biltoft C, Wohl ME, Sanchez J, Feris J, Balter S, Levine OS, Carlone GM. Functional antibody activity elicited by fractional doses of Haemophilus influenzae type b conjugate vaccine (polyribosylribitol phosphate-tetanus toxoid conjugate). Clin Diagn Lab Immunol 2001; 8:1115-9.
7. Campbell JD, Lagos R, Levine MM, Losonosky GA. Standard and alternative regimens of Haemophilus influenzae type b conjugate vaccine (polyribosylribitol phosphate-tetanus toxoid conjugate vaccine) elicit comparable antibody avidities in infants. Pediatr Infect Dis J 2002; 21:822-6.
8. Huebner RE, Nicol M, Morhupi R, Kayhty H, Mbelle N, Khomo E, Klugman KP. Dose response of CRM197 and tetanus toxoid-conjugated Haemophilus influenzae type b vaccines. Vaccine 2004; 23:802-6.
9. Nicol M, Huebner R, Mothupi R, Kayhty H, Mbelle N, Khomo E. Haemophilus influenzae type b conjugate vaccine diluted tenfold in diphtheria-tetanus-whole cell pertussis vaccine: A randomized trial. Pediatr Infect Dis J 2002; 21:138-41.
10. Tregnaghi M, Lopez P, Rocha C, Rivera L, David MP, Ruttimann R, Schuerman L. A new DTPw-HB/Hib combination vaccine for primary and booster vaccination of infants in Latin America. Rev Panam Salud Publica 2006; 19:179-88.
11. Hla KH, Thein SA, Aye A, Han HH, Bock HL, David MP, Schuerman L. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: A randomized dose-ranging trial of the Hib tetanus-conjugate content. Pediatr Infect Dis J 2006; 25:706-12.
12. Cody CL, Baraff LJ, Cherry JD, Marcy SM, Manclark CR. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics 1981; 68:650-60.
13. World Health Organization. Immunization policy: Global programme for vaccines and immunization, expanded programme on immunization. WHO/EPI/GEN/95.03REV.1, 1996.